Clinical trial Recruiting at 1 site Interventional Ages 18 and up

EMG-Directed Virtual-Reality Training for Arm Rehab After Stroke or SCI

Official title: Pilot Study of EMG-Directed Virtual-Reality Experience Training for Motor Stroke Rehabilitation

Run by Imperial College London · NCT07705256 · Data updated 2026-11-12

This study tests whether EMG-controlled virtual reality rehab can help improve arm and hand movement in people after stroke or spinal cord injury.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment24 (estimated)
SponsorImperial College London
Academic / other
Locations1 site (London)
StatusRecruiting
StartedAugust 24, 2026
Main results expectedMay 27, 2027
Study endsNovember 27, 2027
Registry record updatedSeptember 9, 2026
Trial IDNCT07705256 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with a recent stroke (within 2 weeks) or spinal cord injury, able to communicate in English and participate in training, including those with cognitive impairment.

Probably not a fit

Some participants may not experience meaningful improvements in arm function.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants will use a virtual-reality system driven by surface EMG signals to guide upper-limb training after stroke or spinal cord injury. A sub-study will add functional electrical stimulation to assist muscle activation during training. The study will measure changes in arm function and explore links between biological/movement markers and recovery.

Why it matters

Potential benefit: If successful, participants may gain improved arm and hand function and greater independence in daily activities.

How similar studies have gone: Previous research in neuromotor rehabilitation supports EMG-guided feedback as a promising approach, but results vary and this exact combination with VR and FES is less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18 or over
* Cognitive status that would permit for use /supported use of intervention device and engagement in protocol related trainings/assessment. To be indicated by treating clinician at point of screening, formal capacity assessment to be conducted as appropriate. Refer to easy read patient information sheet (PIS) and training materials to support all patients presenting with specific cognitive and/or communication needs.
* (We do not wish to exclude patients with cognitive impairment as this would limit the heterogeneity of our sample and generalizability of our findings, given the prevalence of cognitive impairment in stroke patients.)
* Stroke diagnosis (can be first or subsequent stroke, unilateral haemorrhagic or ischemic) 2 weeks max post stroke at time of recruitment.
* Can communicate in English, that is, sufficient for completion of intervention and outcome measures. A speech and language therapist (SLT) will be consulted if necessary to ensure all reasonable accommodations are made to support participation.
* UL motor deficit post stroke (bilateral/unilateral) (according to National Institutes of Health Stroke Score (NIHSS) item 5), distal UL power \<1 /5 on the Oxford Rating Scale (Medical Research Council Manual Muscle Testing scale).

Exclusion Criteria:

* Patients already enrolled an interventional neuro rehabilitation trial.
* Patients enrolled in clinical trials that contraindicate co-enrolment.
* Patients presenting with unstable medical conditions/medical contraindications as determined by treating medical consultant (these patients may be approached at a later date should their condition improve).
* Those registered blind/with uncompensated/uncorrected visual deficits, including severe neglect that prevents them from being able to focus on visually provided feedback.
* Behavioural/affective dysfunction which could influence the ability of the person to engage with the research protocol and/or pose risk to the participating researchers (in circumstances such as follow-up community visits).
* Other concomitant neurological disorders affecting upper extremity motor function (Multiple Sclerosis, Spinal Cord Injury, Brachial Plexus or Radial Nerve Injury).
* Unremitting arm, wrist or hand pain at rest (Numeric Pain Rating Scale \> 4). Consumption of caffeine 2 hours prior to assessment (assessment will be postponed to a later time).
* Pre-existing UL impairment with known and significant disruption to range of motion, motor or functional performance (fracture, arthritic changes, other known musculoskeletal problems). Or pre-modified Rankin Score \> 2.
* Skin condition apparent on the ventral UE such that might place participant at risk of irritation in the context of repeated physical contact (such as that associated with the intervention).
* Subsequent MRI that fails to confirm stroke
* Chronic stroke patients whose stroke occurred in excess of 2.5 years ago
* Patients whose cognitive impairment prevents them from following instructions

Where it's running

  • Charing Cross Hospital
    London, United Kingdom
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.